pub2calender test1 Ambient AI Scribes in Clinical Practice: A Randomized Trial

📉 Nabla reduced time-in-note by 9.5% compared to controls.
📈 Both AI tools showed improvements in burnouts and task load scores.
🔬 Infrequent inaccuracies observed, necessitating vigilance.
Read full at https://tnyp.me/DkhjcAVB/m
#AIScribes #RCT #ClinicalInnovation

test 2 AI Scribes in Clinical Practice: A Randomized Trial

📉 Nabla reduced time-in-note by 9.5%
🆙 DAX improved Mini-Z score by 2.83
🧠 Similar performance across platforms

#AITech #Healthcare #RCT

https://tnyp.me/jjCiMbO6/m

AI/ML Trends in Clinical Trials (2010-2023)

📈 Rapid increase in AI/ML studies post-2017, 62.8% from 2021-2023
⚕️ 56.2% randomized, 58.9% prospective designs in trials
🏥 Major sponsors: hospitals/clinics (44.2%), academia (28%)
🌍 Dominantly located in high-income countries (75.3%)
📉 Low result reporting: only 5.6% available at study completion

#AI #ML #ClinicalTrials #HIC #RCT #Healthcare #Pub2Post

DOI: https://dev.https://tnyp.me/e6M2kG8b/m

Objective Measurement

It sounded so good.
Goodbye to subjective evaluations like "Could try harder".
Hello to "Afsahna has demonstrated competency in Module 7 of the 3rd year curriculum." Or "The residents have all received their medication by 10am every day."

But it became all too obvious that focussing on what can be measured objectively, in any bureaucratic environment, has the subjective side of things discounted & defunded.

Or worse. As the #CassReport showed.
#ObjectiveMeasurement #RCT